Thursday, Oct. 8, 2020
Mina Mawani, President & CEO of Crohn’s and Colitis Canada
Crohn’s and Colitis Canada has invested more than $130 million in inflammatory bowel research since its founding in 1974. Mina Mawani, President and CEO of Crohn’s and Colitis Canada, discusses the impact of Covid-19 on the charity’s research, fundraising, business operations, national volunteers, patient programs and the 270,000 Canadians living with these chronic bowel diseases.
The Schulich ExecEd is committed to working in partnership with organizations adapting to the demands of doing business in a virtual world. For more information on how Schulich ExecEd can help your organization respond in troubled times, visit our web page, Schulich ExecEd: Your Business Continuity and Learning Partner.